Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Roche Holdings ADR RHHBY

Healthcare
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCQX:RHHBY)

Positive Phase III Results for Genentech's Gazyva Show Superiority to Standard Therapy Alone in People With Lupus Nephritis

Business Wire 2 days ago

Positive Phase III Results Show Xofluza Significantly Reduces the Transmission of Influenza Viruses

Business Wire 9 days ago

FDA Approves Ocrevus Zunovo(TM) as the First and Only Twice-a-Year 10-Minute Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis

Business Wire September 13, 2024

FDA Approves Genentech's Tecentriq Hybreza, the First and Only Subcutaneous Anti-PD-(L)1 Cancer Immunotherapy

Business Wire September 12, 2024

Roche advances AI-driven cancer diagnostics by expanding its digital pathology open environment

PR Newswire September 9, 2024

New Data for Genentech's Susvimo Demonstrates Sustained Efficacy in Two Serious Diabetic Eye Conditions

Business Wire July 18, 2024

Genentech's Vabysmo Showed Extended Durability, Continued Efficacy and a Consistent Safety Profile in Long-Term Diabetic Macular Edema (DME) Study

Business Wire July 17, 2024

Genentech Announces Positive Phase I Results of Its Oral GLP-1 Receptor Agonist CT-996 for the Treatment of People With Obesity

Business Wire July 17, 2024

Remix Therapeutics(TM) Attains Near-Term Milestone from Roche Collaboration

PR Newswire July 10, 2024
View More News ››

Opinion & Analysis (OTCQX:RHHBY)

Potential Alzheimer's therapies focus on early intervention

Streetwise Reports December 1, 2017

Phase 3 trial for Inovio's VGX-3100 in cervical dysplasia gets FDA go-ahead

The Life Sciences Report June 16, 2017

Diffusion Pharmaceuticals takes aim at brain cancer: CEO David Kalergis

The Life Sciences Report April 1, 2016

BTIG's Hartaj Singh's advice for biotech investors: 'hold your powder' 'til winter

Gail Dutton October 1, 2015

Buy biotech when there's blood on the street: Pontifax's Ran Nussbaum

George S. Mack September 3, 2015

Swiss Miss: Switzerland Skirts Recession, But ETFs Struggle

Benzinga.com  August 28, 2015
View More Opinion ››

Bullboard Posts (OTCQX:RHHBY)

Pfizer And Roche Advance On Their Weight Loss Drug Journeys

NEWS: $RHHBY Pfizer And Roche Advance On Their Weight Loss Drug Journeys | BenzingaAfter previously discounting a twice-daily version of...
whytestocks - July 17, 2024

Novartis To Axe 680 Development Jobs Amid Global Reshuffle:

BREAKING NEWS: $RHHBF Novartis To Axe 680 Development Jobs Amid Global Reshuffle: Report | BenzingaNovartis AG@(NYSE:NVS) reportedly...
whytestocks - April 9, 2024

ONE DRUG PILL WIPES OUT COVID 19!

India's Ivermectin Blackout - Part V: The Secret Revealed ...   Sep 27, 2021 · By September 12, 2021...
zeropointenergy - October 6, 2021

Kadcyla Inventor

Took on a role at $APC.v.  $APC.v was selected for a presentation at the World Molegular Imaging Congress.  This is a...
Goldnboy1 - October 5, 2021

looking for pharma partner- amazing-

  9:33NOW PLAYING
goodheart-r - January 25, 2021

Acquires Shares of Foundation Medicine for $2.4B (EN & CH)

Not for distribution in US: Roche Acquires Remaining Shares of Foundation Medicine for $2.4 Billion Three years after acquiring a...
WesternInvestor - June 21, 2018
View more Bullboard ››

Grid Battery Metals Inc.

Grid Battery Metals Inc.

Grid Battery Metals Inc. is a Canada-based exploration company. The Company focuses on exploration for high-value battery ...
View More »